Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$702M |
| 2 |
Applied Materials
AMAT
|
+$507M |
| 3 |
Keurig Dr Pepper
KDP
|
+$387M |
| 4 |
KeyCorp
KEY
|
+$383M |
| 5 |
Visa
V
|
+$349M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$948M |
| 2 |
Broadcom
AVGO
|
+$446M |
| 3 |
NXP Semiconductors
NXPI
|
+$434M |
| 4 |
Analog Devices
ADI
|
+$309M |
| 5 |
Lam Research
LRCX
|
+$269M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6.22% |
| 2 | Technology | 4.92% |
| 3 | Industrials | 4.28% |
| 4 | Consumer Discretionary | 4.13% |
| 5 | Healthcare | 3.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Teleflex
TFX
$5.78B
| $16.3M | 0.01% |
60,797
-87,467
| -59% | -$23.4M |
|
1402
Rocket Pharmaceuticals
RCKT
$363M
| $16.3M | 0.01% |
829,066
+409,564
| +98% | +$7.75M |
|
|
MGP
1403
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $16.2M | 0.01% |
533,270
+126,584
| +31% | +$3.65M |
|
1404
Churchill Downs
CHDN
$6.27B
| $16.2M | 0.01% |
328,518
-288,612
| -47% | -$13.5M |
|
|
MRO
1405
PUT
DELISTED
Marathon Oil Corporation
MRO
| $16.2M | 0.01% |
777,300
-367,800
| -32% | -$7.25M |
|
1406
CALL
Kinder Morgan
KMI
$73B
| $16.2M | 0.01% |
916,100
+686,800
| +300% | +$11.2M |
|
|
EXAS
1407
PUT
DELISTED
Exact Sciences
EXAS
| $16.2M | 0.01% |
270,700
+22,400
| +9% | +$1.21M |
|
1408
PUT
MetLife
MET
$62.1B
| $16.2M | 0.01% |
370,600
-25,300
| -6% | -$1.18M |
|
1409
PetMed Express
PETS
$39.5M
| $16.1M | 0.01% |
366,601
+166,711
| +83% | +$6.46M |
|
1410
CALL
Exelon
EXC
$47.3B
| $16.1M | 0.01% |
530,517
+107,674
| +25% | +$3.08M |
|
1411
PUT
Factset
FDS
$10.1B
| $16.1M | 0.01% |
81,300
+51,900
| +177% | +$10.4M |
|
1412
Dominion Energy
D
$60.5B
| $16.1M | 0.01% |
236,138
-714,649
| -75% | -$46.5M |
|
1413
Sprouts Farmers Market
SFM
$7.71B
| $16.1M | 0.01% |
727,824
-114,155
| -14% | -$2.58M |
|
|
AAMI
1414
Acadian Asset Management
AAMI
$3.3B
| $16M | 0.01% |
1,125,413
+986,904
| +713% | +$15.1M |
|
|
OPLN
1415
Openlane
OPLN
$4.39B
| $16M | 0.01% |
772,545
-242,023
| -24% | -$4.93M |
|
1416
AXIS Capital
AXS
$7.42B
| $16M | 0.01% |
287,931
-659,790
| -70% | -$37.7M |
|
1417
CALL
D.R. Horton
DHI
$41.8B
| $16M | 0.01% |
390,500
-361,100
| -48% | -$15.6M |
|
1418
Humana
HUM
$46.4B
| $16M | 0.01% |
53,721
-57,508
| -52% | -$16.8M |
|
1419
Ashland
ASH
$3.35B
| $16M | 0.01% |
204,347
-468,681
| -70% | -$34.9M |
|
1420
UroGen Pharma
URGN
$2.33B
| $16M | 0.01% |
321,034
+239,676
| +295% | +$13.9M |
|
|
DOCU
1421
CALL
DocuSign
DOCU
$11.7B
| $15.9M | 0.01% |
+300,700
| New | +$15.2M |
|
1422
Celanese
CE
$4.97B
| $15.9M | 0.01% |
143,220
-130,438
| -48% | -$14.4M |
|
1423
PUT
Ralph Lauren
RL
$23.2B
| $15.9M | 0.01% |
126,300
-5,500
| -4% | -$668K |
|
1424
PUT
Lumen
LUMN
$6.66B
| $15.8M | 0.01% |
850,300
+42,400
| +5% | +$770K |
|
|
HTZ
1425
PUT
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $15.8M | 0.01% |
1,188,408
+511,044
| +75% | +$8.28M |
|
Similar funds
Ken Griffin's Q2 2018 Portfolio in Review
As of Q2 2018, Ken Griffin held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,159 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.
By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 5% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.
- Ken Griffin's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
- Ken Griffin added most to Citigroup in Q2 2018, an estimated $702M increase.
- Ken Griffin's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
- Ken Griffin fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
- Ken Griffin's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
- Ken Griffin opened 1,572 new positions and closed 1,012 in Q2 2018.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $203B.
Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.